The Decreasing Incidence of Late Posttraumatic Acute Respiratory Distress Syndrome: the Potential Role of Lung Protective Ventilation and Conservative Transfusion Practice

2008 ◽  
Vol 2008 ◽  
pp. 15-16
Author(s):  
D.J. Dries
Keyword(s):  
Acute Respiratory Distress Syndrome ◽  
Respiratory Distress Syndrome ◽  
Respiratory Distress ◽  
Potential Role ◽  
Distress Syndrome ◽  
Transfusion Practice ◽  
Protective Ventilation ◽  
Lung Protective Ventilation

scholarly journals COVID19 Acute respiratory distress syndrome and extra-corporeal membrane oxygenation; A mere option or ultimate necessity

Perfusion ◽  
2020 ◽  
pp. 026765912096150
Author(s):  
Taha Ahmed ◽  
Talha Ahmed ◽  
Hussain Karimi ◽  
Leslie Tolle ◽  
Muhammad Nouman Iqbal
Keyword(s):  
Acute Respiratory Distress Syndrome ◽  
Respiratory Distress Syndrome ◽  
Respiratory Distress ◽  
Potential Role ◽  
Distress Syndrome ◽  
Case Fatality ◽  
Lung Protective Ventilation ◽  
Membrane Oxygenation ◽  
Exponential Increase ◽  
Refractory Hypoxemia

Extracorporeal membrane oxygenation (ECMO) is considered a salvage therapy in patients with acute respiratory distress syndrome (ARDS) and refractory hypoxemia (hypoxemia persisting despite lung-protective ventilation). One aspect of ECMO is whether there would be an application of the technology related to the Coronavirus pandemic. The number of people diagnosed with Coronavirus disease (COVID19) has crossed the five million mark on 9 August 2020, with a case fatality rate of 5.2%. Due to this exponential increase in the number of coronavirus disease (COVID19) cases particularly the ones associated with ARDS, experts are evaluating the need for ECMO in intensive care units. Herein, we chronicle a review encompassing the available evidence on ECMO and its potential role in COVID19 ARDS, as we aim for optimal patient care with appropriate resource utilization and conservation.

Sign in / Sign up

Export Citation Format

Share Document